ACWHealth CareCompany Update19 Nov 202619 November 2026· 3 min read
Actinogen Medical (ASX: ACW) Alzheimer’s Trial Misses Primary Endpoint
Actinogen Medical’s pivotal XanaMIA Alzheimer’s trial missed its primary endpoint across the overall population. The company will conserve cash and examine a stronger result in patients older than 75.